Cordova Ashley - Mar 2, 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Chief Financial Officer
Signature: Steven Robbins, as attorney in fact for Cordova, Ashley
Stock symbol: NVCR
Transactions as of: Mar 2, 2023
Transactions value $: -$79,418
Form type: 4
Date filed: 3/6/2023, 03:40 PM
Previous filing: Mar 2, 2023
Next filing: Mar 7, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Sale	-$79.4K	-1.06K	-1.1%	$75.28	95K	Mar 2, 2023	Direct	F1
transaction	NVCR	Ordinary Shares	Award	$0	+11.8K	+12.43%	$0.00	107K	Mar 3, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	Represents vesting of performance-based restricted stock units.

Content

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Represents vesting of performance-based restricted stock units.